Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections
出版年份 2022 全文链接
标题
Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections
作者
关键词
-
出版物
Open Forum Infectious Diseases
Volume 9, Issue 5, Pages -
出版商
Oxford University Press (OUP)
发表日期
2022-03-08
DOI
10.1093/ofid/ofac116
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
- (2022) Mark G. Thompson et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021
- (2022) Christina Yek et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
- (2021) Tal Brosh-Nissimov et al. CLINICAL MICROBIOLOGY AND INFECTION
- Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
- (2021) Adeel A. Butt et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination
- (2021) Adeel A. Butt et al. JOURNAL OF INFECTION
- Hospitalisation among vaccine breakthrough COVID-19 infections
- (2021) Prerak V Juthani et al. LANCET INFECTIOUS DISEASES
- Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
- (2021) Mark G. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
- (2021) Jocelyn Keehner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021
- (2021) Srinivas Nanduri et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021
- (2021) Heather M. Scobie et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021
- (2021) Kristina L. Bajema et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021
- (2021) Shaun J. Grannis et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
- (2021) Wesley H. Self et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
- (2021) Mark W. Tenforde et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes
- (2021) Eyal Leshem et al. Lancet Respiratory Medicine
- Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine
- (2021) Luisa F. Duarte et al. Frontiers in Immunology
- Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance — COVID-NET, 14 States, January–August 2021
- (2021) Christopher A. Taylor et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021
- (2021) Peter J. Embi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Vaccine breakthrough infections in veterans hospitalized with coronavirus infectious disease-2019: A case series
- (2021) Paul S. Kim et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Characteristics Associated with Hospitalization Among Patients with COVID-19 — Metropolitan Atlanta, Georgia, March–April 2020
- (2020) Marie E. Killerby et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020
- (2020) Erin K. Stokes et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit
- (2020) Geehan Suleyman et al. JAMA Network Open
- The Impact of Sociodemographic Factors, Comorbidities, and Physiologic Responses on 30-Day Mortality in Coronavirus Disease 2019 (COVID-19) Patients in Metropolitan Detroit
- (2020) Joseph Miller et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started